CD28-Autoantibodies in Melanoma patients - a new prognostic Marker?

被引：0
|
作者：
Schmaltz, R. [1 ]
Madjidi, D. [1 ]
Preuss, K.-D. [2 ,3 ]
Mueller, C. S. [1 ]
Pfreundschuh, M. [2 ,3 ]
Graeber, S. [4 ]
Vogt, T. [1 ]
Pfoehler, C. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Dermatol Venerol & Allergol, Homburg, Germany
[2] Univ Klinikum Saarlandes, Innere Med Klin 1, Homburg, Germany
[3] Univ Klinikum Saarlandes, Jose Carreras Zentrum Immun & Gentherapie, Homburg, Germany
[4] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Med Informat, Homburg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [21] CD44: A New Prognostic Marker in Colorectal Cancer?
    Ziranu, Pina
    Pretta, Andrea
    Aimola, Valentina
    Cau, Flaviana
    Mariani, Stefano
    D'Agata, Alessandra Pia
    Codipietro, Claudia
    Rizzo, Daiana
    Dell'Utri, Veronica
    Sanna, Giorgia
    Moledda, Giusy
    Cadoni, Andrea
    Lai, Eleonora
    Puzzoni, Marco
    Pusceddu, Valeria
    Castagnola, Massimo
    Scartozzi, Mario
    Faa, Gavino
    CANCERS, 2024, 16 (08)
  • [22] CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER
    Borghese, G.
    Lanzo, G.
    Benvenuto, R.
    Arisio, R.
    Katsaros, D.
    Volante, M.
    Rapa, I.
    Ortolan, E.
    Benedetto, C.
    Funaro, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 26 - 26
  • [23] Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
    Humphrey, G
    Hazel, DL
    MacLennan, K
    Lewis, I
    BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 918 - 921
  • [24] Autoantibodies against CD28 in Melanoma Patients have Immunosuppressive Effects on T cells and may represent a Biomarker of Dismal Prognosis
    Pfoeher, C.
    Koerner, R.
    Madjidi, D.
    Bergeler, L.
    Graeber, S.
    Neumann, F.
    Pfeundschuh, M.
    Mueller, C.
    Vogt, T.
    Preuss, K. -D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 15 - 15
  • [25] New Prognostic Marker for Melanoma? High ECP Levels, poor Outcome
    不详
    HAUTARZT, 2019, 70 (06): : 396 - 396
  • [26] Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients
    Speeckaert, Reinhart
    Vermaelen, Karim
    van Geel, Nanja
    Autier, Philippe
    Lambert, Jo
    Haspeslagh, Marc
    van Gele, Mireille
    Thielemans, Kris
    Neyns, Bart
    Roche, Nathalie
    Verbeke, Natacha
    Deron, Philippe
    Speeckaert, Marijn
    Brochez, Lieve
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 2004 - 2011
  • [27] XIAP as a prognostic marker for Malignant Melanoma
    Emanuel, PO
    Shafir, M
    Burstein, DE
    Mudgil, A
    Phelps, RG
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 71 - 72
  • [28] Metallothioneins as a prognostic marker in primary melanoma
    Weinlich, G.
    Hassler, E.
    Baltaci, M.
    Eisendle, K.
    Fritsch, P.
    Zelger, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S18 - S18
  • [29] Osteopontin as a molecular prognostic marker for melanoma
    Rangel, Javier
    Nosrati, Mehdi
    Torabian, Sima
    Shaikh, Ladan
    Leong, Stanley P. L.
    Haqq, Chris
    Miller, James R., III
    Sagebiel, Richard W.
    Kashani-Sabet, Mohammed
    CANCER, 2008, 112 (01) : 144 - 150
  • [30] MMP2 expression is a prognostic marker for primary melanoma patients
    Anand Rotte
    Magdalena Martinka
    Gang Li
    Cellular Oncology, 2012, 35 : 207 - 216
12345